Visualization of Positive Transcription Elongation Factor B (P-TEFb) Activation in Living Cells

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2014 Dec 11

PMID 25492871

Citations 19

Authors

Koh Fujinaga

Zeping Luo

Fred Schaufele

B Matija Peterlin

Affiliations

Soon will be listed here.

Abstract

Regulation of transcription elongation by positive transcription elongation factor b (P-TEFb) plays a central role in determining the state of cell activation, proliferation, and differentiation. In cells, P-TEFb exists in active and inactive forms. Its release from the inactive 7SK small nuclear ribonucleoprotein complex is a critical step for P-TEFb to activate transcription elongation. However, no good method exists to analyze this P-TEFb equilibrium in living cells. Only inaccurate and labor-intensive cell-free biochemical assays are currently available. In this study, we present the first experimental system to monitor P-TEFb activation in living cells. We created a bimolecular fluorescence complementation assay to detect interactions between P-TEFb and its substrate, the C-terminal domain of RNA polymerase II. When cells were treated with suberoylanilide hydroxamic acid, which releases P-TEFb from the 7SK small nuclear ribonucleoprotein, they turned green. Other known P-TEFb-releasing agents, including histone deacetylase inhibitors, bromodomain and extraterminal bromodomain inhibitors, and protein kinase C agonists, also scored positive in this assay. Finally, we identified 5'-azacytidine as a new P-TEFb-releasing agent. This release of P-TEFb correlated directly with activation of human HIV and HEXIM1 transcription. Thus, our visualization of P-TEFb activation by fluorescent complementation assay could be used to find new P-TEFb-releasing agents, compare different classes of agents, and assess their efficacy singly and/or in combination.

Citing Articles

Transcription elongation defects link oncogenic SF3B1 mutations to targetable alterations in chromatin landscape.

Boddu P, Gupta A, Roy R, de la Pena Avalos B, Olazabal-Herrero A, Neuenkirchen N Mol Cell. 2024; 84(8):1475-1495.e18.

PMID: 38521065 PMC: 11061666. DOI: 10.1016/j.molcel.2024.02.032.

CDK9 activity switch associated with AFF1 and HEXIM1 controls differentiation initiation from epidermal progenitors.

Lloyd S, Leon D, Brady M, Rodriguez D, McReynolds M, Kweon J Nat Commun. 2022; 13(1):4408.

PMID: 35906225 PMC: 9338292. DOI: 10.1038/s41467-022-32098-2.

Discovery of a large-scale, cell-state-responsive allosteric switch in the 7SK RNA using DANCE-MaP.

Olson S, Turner A, Arney J, Saleem I, Weidmann C, Margolis D Mol Cell. 2022; 82(9):1708-1723.e10.

PMID: 35320755 PMC: 9081252. DOI: 10.1016/j.molcel.2022.02.009.

Establishment of a fluorescent reporter of RNA-polymerase II activity to identify dormant cells.

Freter R, Falletta P, Omrani O, Rasa M, Herbert K, Annunziata F Nat Commun. 2021; 12(1):3318.

PMID: 34083536 PMC: 8175728. DOI: 10.1038/s41467-021-23580-4.

Latency Reversing Agents: Kick and Kill of HTLV-1?.

Schnell A, Kohrt S, Thoma-Kress A Int J Mol Sci. 2021; 22(11).

PMID: 34073995 PMC: 8197370. DOI: 10.3390/ijms22115545.

References

Wittmann B, Fujinaga K, Deng H, Ogba N, Montano M . The breast cell growth inhibitor, estrogen down regulated gene 1, modulates a novel functional interaction between estrogen receptor alpha and transcriptional elongation factor cyclin T1. Oncogene. 2005; 24(36):5576-88. DOI: 10.1038/sj.onc.1208728. View

Bartholomeeusen K, Xiang Y, Fujinaga K, Peterlin B . Bromodomain and extra-terminal (BET) bromodomain inhibition activate transcription via transient release of positive transcription elongation factor b (P-TEFb) from 7SK small nuclear ribonucleoprotein. J Biol Chem. 2012; 287(43):36609-16. PMC: 3476326. DOI: 10.1074/jbc.M112.410746. View

Fanara P, Hodel M, Corbett A, Hodel A . Quantitative analysis of nuclear localization signal (NLS)-importin alpha interaction through fluorescence depolarization. Evidence for auto-inhibitory regulation of NLS binding. J Biol Chem. 2000; 275(28):21218-23. DOI: 10.1074/jbc.M002217200. View

Izeddin I, Recamier V, Bosanac L, Cisse I, Boudarene L, Dugast-Darzacq C . Single-molecule tracking in live cells reveals distinct target-search strategies of transcription factors in the nucleus. Elife. 2014; 3. PMC: 4095940. DOI: 10.7554/eLife.02230. View

He N, Liu M, Hsu J, Xue Y, Chou S, Burlingame A . HIV-1 Tat and host AFF4 recruit two transcription elongation factors into a bifunctional complex for coordinated activation of HIV-1 transcription. Mol Cell. 2010; 38(3):428-38. PMC: 3085314. DOI: 10.1016/j.molcel.2010.04.013. View

Ott M, Geyer M, Zhou Q . The control of HIV transcription: keeping RNA polymerase II on track. Cell Host Microbe. 2011; 10(5):426-35. PMC: 3478145. DOI: 10.1016/j.chom.2011.11.002. View

Contreras X, Barboric M, Lenasi T, Peterlin B . HMBA releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K/Akt and activates HIV transcription. PLoS Pathog. 2007; 3(10):1459-69. PMC: 2014796. DOI: 10.1371/journal.ppat.0030146. View

Napolitano G, Licciardo P, Carbone R, Majello B, Lania L . CDK9 has the intrinsic property to shuttle between nucleus and cytoplasm, and enhanced expression of cyclin T1 promotes its nuclear localization. J Cell Physiol. 2002; 192(2):209-15. DOI: 10.1002/jcp.10130. View

Fernandez G, Zeichner S . Cell line-dependent variability in HIV activation employing DNMT inhibitors. Virol J. 2010; 7:266. PMC: 2964676. DOI: 10.1186/1743-422X-7-266. View

10.

Kerppola T . Visualization of molecular interactions using bimolecular fluorescence complementation analysis: characteristics of protein fragment complementation. Chem Soc Rev. 2009; 38(10):2876-86. PMC: 2980501. DOI: 10.1039/b909638h. View

11.

Robida A, Kerppola T . Bimolecular fluorescence complementation analysis of inducible protein interactions: effects of factors affecting protein folding on fluorescent protein fragment association. J Mol Biol. 2009; 394(3):391-409. PMC: 2862259. DOI: 10.1016/j.jmb.2009.08.069. View

12.

Czudnochowski N, Bosken C, Geyer M . Serine-7 but not serine-5 phosphorylation primes RNA polymerase II CTD for P-TEFb recognition. Nat Commun. 2012; 3:842. DOI: 10.1038/ncomms1846. View

13.

Yang Z, Zhu Q, Luo K, Zhou Q . The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription. Nature. 2001; 414(6861):317-22. DOI: 10.1038/35104575. View

14.

Bartholomeeusen K, Fujinaga K, Xiang Y, Peterlin B . Histone deacetylase inhibitors (HDACis) that release the positive transcription elongation factor b (P-TEFb) from its inhibitory complex also activate HIV transcription. J Biol Chem. 2013; 288(20):14400-14407. PMC: 3656295. DOI: 10.1074/jbc.M113.464834. View

15.

Okamura D, Maeda I, Taniguchi H, Tokitake Y, Ikeda M, Ozato K . Cell cycle gene-specific control of transcription has a critical role in proliferation of primordial germ cells. Genes Dev. 2012; 26(22):2477-82. PMC: 3505818. DOI: 10.1101/gad.202242.112. View

16.

Price D . Poised polymerases: on your mark...get set...go!. Mol Cell. 2008; 30(1):7-10. DOI: 10.1016/j.molcel.2008.03.001. View

17.

Peterlin B, Brogie J, Price D . 7SK snRNA: a noncoding RNA that plays a major role in regulating eukaryotic transcription. Wiley Interdiscip Rev RNA. 2011; 3(1):92-103. PMC: 3223291. DOI: 10.1002/wrna.106. View

18.

Biglione S, Byers S, Price J, Nguyen V, Bensaude O, Price D . Inhibition of HIV-1 replication by P-TEFb inhibitors DRB, seliciclib and flavopiridol correlates with release of free P-TEFb from the large, inactive form of the complex. Retrovirology. 2007; 4:47. PMC: 1948018. DOI: 10.1186/1742-4690-4-47. View

19.

Bres V, Yoh S, Jones K . The multi-tasking P-TEFb complex. Curr Opin Cell Biol. 2008; 20(3):334-40. PMC: 2628440. DOI: 10.1016/j.ceb.2008.04.008. View

20.

Kim Y, Mbonye U, Hokello J, Karn J . T-cell receptor signaling enhances transcriptional elongation from latent HIV proviruses by activating P-TEFb through an ERK-dependent pathway. J Mol Biol. 2011; 410(5):896-916. PMC: 3139146. DOI: 10.1016/j.jmb.2011.03.054. View